Skip to main content
TipRanks
Go Ultimate75% OFF

Invus US Partners LLC Insider Profile

4 Followers

Invus US Partners LLC, Director, Ten Percent Owner at Lexicon Pharmaceuticals, holds 5.78M shares in Lexicon Pharmaceuticals (Ticker: LXRX). Most recently, Invus US Partners LLC Bought 147,390 shares of Lexicon Pharmaceuticals on Aug 09, 2022 for an estimated value of $368.48K.

Invus US Partners LLC's Trading History

LXRX
Lexicon Pharmaceuticals
Aug 09, 2022Director, Ten Percent OwnerInformative Buy368.48K$10.35M
LXRX
Insider Shares: 5.78M (3.15%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 09, 2022Informative Buy$368.48K147,390$2.50-32.40%
Aug 01, 2022Informative Buy$2.46M982,600$2.50-18.10%

You May Also Like

Invus US Partners LLC insider profile FAQ

What is the percentage of profitable transactions made by Invus US Partners LLC?
The percentage of profitable transactions made by Invus US Partners LLC is 0%.
What is the average return per transaction made by Invus US Partners LLC?
The average return per transaction made by Invus US Partners LLC is -25.20%.
What stocks does Invus US Partners LLC hold?
Invus US Partners LLC holds: LXRX stocks.
What was Invus US Partners LLC’s latest transaction?
Invus US Partners LLC’s latest transaction was an Informative Buy of $368.48K.
What was Invus US Partners LLC's most profitable transaction?
Invus US Partners LLC’s most profitable transaction was an Informative Buy of LXRX stock on August 1, 2022. The return on the trade was -18.10%.
What is Invus US Partners LLC's role in Lexicon Pharmaceuticals?
Invus US Partners LLC's role in Lexicon Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.